|
1
|
World Health Organization (WHO), .
Prevention of Cardiovascular disease: Guidelines for assessment and
management of cardiovascular risk. WHO Library; Geneva,
Switzerland: 2007
|
|
2
|
Onat A, Yazıcı M, Sarı İ, Türkmen S,
Uzunlar B and Uyarel H ve ark: TEKHARF 2003 yılı tarama takibi:
ölüm ve koroner olaylara ilişkin sonuçlar şehirlilerde mortalitenin
azaldığına işaret. Türk Kardiyol Dern Arş. 31:762–769. 2003.(In
Turkish).
|
|
3
|
Ross R: Atherosclerosis - an inflammatory
disease. N Eng J Med. 340:115–126. 1999. View Article : Google Scholar
|
|
4
|
O'Dea E and Hoffmann A: NF-κB signaling.
Wiley Interdiscip Rev Syst Biol Med. 1:107–115. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Heron E, Deloukas P and Van Loon AP: The
complete exon-intron structure of the 150-kb human gene NFKB1,
which encodes p105 and p50 proteins of transcription factors
NF-kappa B and I kappa B-gamma: Implications for NF-kappa
B-mediated signal transduction. Genomics. 30:493–505. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pereira SG and Oakley F: Nuclear
factor-kappaB1: Regulation and function. Int J Biochem Cell Biol.
40:1425–1430. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chiao PJ, Miyamoto S and Verma IM:
Autoregulation of I kappa B alpha activity. Proc Natl Acad Sci USA.
91:28–32. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Baeuerle PA: IkappaB-NF-kappaB structures:
At the interface of inflammation control. Cell. 95:729–731. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Arslan S and Engin A: Relationship between
NF-κB1 and NF-κBIA genetic polymorphisms and Crimean-Congo
hemorrhagic fever. Scand J Infect Dis. 44:138–143. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yeh FC and Boyle TJB: Population genetic
analysis of co-dominant and dominant markers and quantitative
traits. Belgian Journal of Botany. 129:1571997.
|
|
11
|
Terwilliger JD and Ott J: A novel
polylocus method for linkage analysis using the lod-score or
affected sib-pair method. Genet Epidemiol. 10:477–482. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Romzova M, Hohenadel D, Kolostova K, et
al: NF-κB and its inhibitor IκB in relation to type 2 diabetes and
its microvascular and atherosclerotic complications. Hum Immunol.
67:706–713. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Curran JE, Weinstein SR and Griffiths LR:
Polymorphic variants of NFKB1 and its inhibitory protein NFKBIA,
and their involvement in sporadic breast cancer. Cancer Lett.
188:103–107. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Özbilüm N, Arslan S, Berkan Ö, Yanartaş M
and Aydemir EI: The role of NF-κB1A promoter polymorphisms on
coronary artery disease risk. Basic Clin Pharmacol Toxicol.
113:187–192. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Klein W, Tromm A, Folwaczny C, Hagedorn M,
Duerig N, Epplen JT, Schmiegel WH and Griga T: Polymorphism of the
NFKBIA gene is associated with Crohn's disease patients lacking a
predisposing allele of the CARD15 gene. Int J Colorectal Dis.
19:153–156. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Parker KM, Ma MH, Manyak S, et al:
Identification of polymorphisms of the IκBα gene associated with an
increased risk of multiple myeloma. Cancer Genet Cytogenet.
137:43–48. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lin CW, Hsieh YS, Hsin CH, et al: Effects
of NFKB1 and NFKBIA gene polymorphisms on susceptibility to
environmental factors and the clinicopathologic development of oral
cancer. PLoS One. 7:e350782012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang P, Wei Q, Li X, et al: A functional
insertion/deletion polymorphism in the promoter region of the NFKB1
gene increases susceptibility for prostate cancer. Cancer Genet
Cytogenet. 191:73–77. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liang M, Xu X, Gong Y, Tang Y and Lin L:
Risk association between the NF-κB1 −94ins/delATTG promoter
polymorphism and inflammatory bowel diseases: A meta-analysis. Dig
Dis Sci. 57:2304–2309. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zou YF, Wang F, Feng XL, Tao JH, Zhu JM,
Pan FM and Su H: Association of NFKB1 −94ins/delATTG promoter
polymorphism with susceptibility to autoimmune and inflammatory
diseases: A meta-analysis. Tissue Antigens. 77:9–17. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Karban AS, Okazaki T, Panhuysen CI, et al:
Functional annotation of a novel NFKB1 promoter polymorphism that
increases risk for ulcerative colitis. Hum Mol Genet. 13:35–45.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Vogel U, Jensen MK, Due KM, et al: The
NFKB1 ATTG ins/del polymorphism and risk of coronary heart disease
in three independent populations. Atherosclerosis. 219:200–204.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen Z, Ma G, Qian Q, Yao Y, Feng Y and
Tang C: Toll-like receptor 8 polymorphism and coronary artery
disease. Mol Biol Rep. 36:1897–1901. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hotamisligil GS: Inflammation and
metabolic disorders. Nature. 444:860–867. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Elliott P, Chambers JC, Zhang W, et al:
Genetic Loci associated with C-reactive protein levels and risk of
coronary heart disease. JAMA. 302:37–48. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
ChaMolstad H, Agrawal A, Zhang D, Samols D
and Kushner I: The Rel family member P50 mediates cytokine-induced
C-reactive protein expression by a novel mechanism. J Immunol.
165:4592–4597. 2000. View Article : Google Scholar : PubMed/NCBI
|
